Results 71 to 80 of about 2,139 (156)

Adjuvante Therapie des schweren und/oder refraktären bullösen Pemphigoids mit Immunadsorption – eine prospektive monozentrische Pilotstudie

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 4, Page 472-481, April 2026.
Zusammenfassung Hintergrund und Zielsetzung Das bullöse Pemphigoid (BP) ist die häufigste blasenbildende Autoimmunerkrankung in der westlichen Welt. Während die Mehrheit der Patienten mit BP durch die langfristige Anwendung von Kortikosteroiden mit oder ohne Immunmodulatoren/Immunsuppressiva Remissionen erreicht, empfehlen nationale und internationale ...
Maike M. Holtsche, Nina van Beek, Christoph M. Hammers, Artem Vorobyev, Michael Kasperkiewicz, Nina Schumacher, Philip Muck, Enno Schmidt   +7 more
wiley   +1 more source

A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors

Frontiers in Immunology, 2019
Background: Anti-hyperglycemic drug dipeptidyl peptidase-IV inhibitors (DPP-4i) have recently been recognized as bullous pemphigoid (BP) inducing drugs. It remains uncertain whether DPP-4i induce BP-IgG autoantibodies before the onset of BP.Objective: To
Kentaro Izumi, Wataru Nishie, Mutsuo Beniko, Hiroshi Shimizu   +3 more
doaj   +1 more source

Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180

Frontiers in Immunology, 2019
Bullous pemphigoid (BP) is a common autoimmune blistering disease in which autoantibodies target the hemidesmosomal components BP180 and/or BP230 in basal keratinocytes.
Yosuke Mai, Wataru Nishie, Kentaro Izumi, Hiroshi Shimizu   +3 more
doaj   +1 more source

Penfigóide Bolhoso Refractário em Paciente Infectado pelo Vírus da Imunodeficiência Humana

Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2018
Penfigóide bolhoso, a dermatose bolhosa subepidérmica auto-imune mais comum, é devida a auto-anticorpos contra partículas dos hemidesmosmas (BP180 e/ou BP230) e caracteriza-se por prurido e bolhas cutâneas tensas sobre base eritematosa ou pele normal ...
Chan I Thien, Mariana Rita de Novaes Fernandes, Marcella D’Elia Novello, Fernanda Cabral, Aline Lopes Bressan, Juan Manuel Piñeiro-Maceira, Alexandre Carlos Gripp   +6 more
doaj   +1 more source

180-kd bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis-bullosa [PDF]

, 1995
Generalized atrophic benign epidermolysis bullosa (GABEB) is a form of nonlethal junctional epidermolysis bullosa characterized by universal alopecia and atrophy of the skin.
M F Jonkman, J B van der Meer, Develasco, AMM, K Owaribe, Heeres, K, de Jong, MCJM, A M Martinez de Velasco, Jonkman, MF, Niessen, CM, A Sonnenberg, van der Meer, JB, H H Pas, Owaribe, K, K Heeres, Pas, HH, Sonnenberg, A, M C de Jong, C M Niessen   +17 more
core   +2 more sources

Penfigoide bolhoso no adulto mais jovem: relato de três casos Bullous pemphigoid in younger adults: three case reports

Anais Brasileiros de Dermatologia, 2011
O penfigoide bolhoso é uma dermatose bolhosa autoimune subepidérmica, mais comumente observada na população idosa (acima dos 70 anos). Autoanticorpos são formados contra antígenos específicos da zona de membrana basal: BP180 e BP230 (proteínas do ...
Roberta Richter Zanella, Tamar Alencar Xavier, Antônio José Tebcherani, Valéria Aoki, Ana Paula Galli Sanchez   +4 more
doaj   +1 more source

Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease [PDF]

, 2016
Bullous pemphigoid (BP) is a subepidermal blistering skin disease, which has shown a strong association with neurological diseases in epidemiological studies.
Huilaja, Laura, Koivisto, Anne M., Remes, Anne M., Hartikainen, Päivi, Herukka, Sanna-Kaisa, Tasanen, Kaisa, Kokkonen, Nina, Kokki, Merja   +7 more
core   +1 more source

Detection of autoantibodies against BP180 and BP230 antigens as a method for diagnosis and follow up of patients with bullous pemphigoid

, 2008
The aim of this study is to investigate the possible relation of circulating autoantibodies against BP180 and BP230 with the activity of the disease and to evaluate the usefulness of the immunoenzymic method ELISA for diagnosis and follow up of patients ...
Πατσατσή, Αικατερίνη, Patsatsi, Aikaterini   +1 more
core   +1 more source

Bullous pemphigoid: Serum antibody titre and antigen specificity

, 1995
2 antigens have been identified as possible targets for autoantibody depositions in bullous pemphigoid: a 230-kD protein (BP230) and a 180-kD protein (BP180).
Marcelus C. J. M. de Jong, Jan B. van der Meer, van der Meer, J B, Klaas Heeres, Heeres, K, Hendri H. Pas, Marcel E Jonkman, Pas, H H, Slijper-Pal, I J, de Jong, M C, Ida J. Slijper‐Pal, Jonkman, M F   +11 more
core   +1 more source

Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score

, 2018
BACKGROUND: Bullous pemphigoid (BP) is a subepidermal blistering disease characterized by autoantibodies against the two hemidesmosomal proteins, BP180 (type XVII collagen) and BP230.
Walton, S., S. Benoit, Williams, H. C., I.R. König, K. Harman, A. Chapman, M. Sticherling, Sticherling, M., Benoit, S., J. English, English, J., van Beek, N., Schmidt, E., Levell, N. J., D. Zillikens, S. Goletz, Goletz, S., N. van Beek, Groves, R., König, I. R., R. Groves, Zillikens, D., M.M. Holtsche, Harman, K., E. Schmidt, null null, Chapman, A., N.J. Levell, S. Walton, Holtsche, M. M., H.C. Williams   +30 more
core   +1 more source